A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

581

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms

Interventions

DRUG: Trabectedin
DRUG: DOXIL
DRUG: Dexamethasone
DRUG: DOXIL

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]